Cancer Funding Becoming an Issue in the US Presidential Race

by Gopalan on August 29, 2007 at 11:57 AM
Cancer Funding Becoming an Issue in the US Presidential Race

In a nation torn apart over a war in a faraway land, cancer could become a consensus point, it looks like.

Cyclist Lance Armstrong seems to be succeeding in his efforts to push cancer funding to the top of the national agenda as the presidential election is nearing.


Lance Armstrong with Democratic Presidential Candidate John Edward

At the presidential forums he organized at Iowa the last two days, those candidates who showed up agreed that there was a dire need to step up funding, of course the Democrats were far more vociferous.

Only two of the eight Republicans cared to take part, unwilling as they were to take public position on raising resources for cancer funding. Still the two forums attracted a good audience and commentators believe it is a step forward.

The Democratic candidates attacked the Bush administration for cutting research money to the National Cancer Institute.

'The current administration has literally called a halt in the war against cancer,' Hillary Clinton said, adding that 'the president of the United States has been leading an assault on science and research.'

She herself had to face some embarrassing moments when her rival John Edwards blamed her for being too close to industry lobbyists.

Edwards, a former North Carolina senator, has continually chided Clinton, a New York senator, for taking campaign donations from special-interest lobbyists. He said it was the healthcare industry's actions that led to her failure as first lady to get national health care enacted in the early 1990s.

'I believe that the insurance companies, the drug companies and their lobbyists killed the healthcare reform that was attempted in the 1990s by Sen. Clinton, and we applaud her for her work. But I think they're the people who killed it,' Edwards said.

'My lesson [from that] is not the same as hers. Her lesson is, 'Give them a seat at the table,'' Edwards said. 'I think if you give drug companies and insurance companies and their lobbyists a seat at the table, they'll eat all the food.'

Clinton maintained that industry contributions she has received as a candidate have not stopped her from pushing expanded healthcare initiatives and changes in pharmaceutical regulations.

'I believe in working with everybody and being influenced by nobody,' Clinton said. 'I think that the idea that we need a national health-care system is great, and I'm all for it and I'm going to make sure that it happens.'

Whatever the exchanges among themselves, the fact remains all the four Democrats committed themselves to at least doubling the $5 billion spent annually for cancer research—in other words, to backing a 'surge' in the long-neglected war on cancer. Considering that cancer kills 550,000 Americans a year (that's 1,500 a day—the leading cause of death for those under 85), it's about time. As Bill Richardson said, 'it's pathetic' that we now spend the same in two weeks in Iraq as we spend all year fighting cancer.

The candidates also said expansion of health-care coverage to the millions of uninsured Americans was crucial to fighting cancer. 'We so desperately need universal health care,' Edwards said.

He took note of the millions of people with cancer who don't have the advantages he and his wife Elizabeth enjoy. They lose all their money, he said, on top of getting sick. But even the Edwardses cannot read their incomprehensible medical bills.

And Edwards, along with the other candidates, believes that insurance companies often limit necessary treatment. He also noted that only two in 10 proposals for cancer research get funded these days. This is driving young reseachers out of oncology toward other fields, dramatically slowing the search for cures. Until recently, when cancer budgets were cut by President Bush, it was five of 10.

On the second day of Lance Armstrong's Livestrong Presidential Cancer Forum, only two of the eight invited Republican candidates showed up.

Senator Brownback, himself a melanoma survivor, scored some points by emphasizing his efforts to ease the availability of experimental drugs for end-stage cancer patients, which the FDA continues to make difficult, at a cost of thousands of lives.

He, however, refused to be pinned down on cancer research funding. He said he wanted to start with a pledge to end cancer deaths in ten years, then assess how much money would be required. Arkansas Governor Mike Huckabee talked about a food-stamp program that would offer financial incentives for healthy choices, so that a dollar in food stamps would buy $1.25 worth of fruit and vegetables but only 75 cents worth of junk food.

Both had to wrestle a lot of questions on health-related issues at the forum, and that is a welcome change from the usual campaign din.

Every candidate will now be asked: Do you favor doubling the funding for cancer research? And if not, to what better use would you put that money?

Ultimately, politicians are forced to deal with the real issues in people's lives. With cancer touching every family in the country, we may be seeing the beginning of new priorities in the big tent of American politics, columnist Jonathan Alter remarked.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Cancer News

Anti-allergy Drug Dupilumab Treats Lung Cancer
Researchers found a pathway linked to allergies that, when blocked, triggers antitumor immunity in lung cancer mouse models.
Early Gene Epimutation Linked to Breast Cancer
The occurrence of epimutations early in pregnancy challenges traditional theories related to carcinogenesis and the risk of developing breast cancer.
Does Family History Heighten Lung Cancer Risk?
More affected relatives, higher lung cancer risk; participants with affected mothers or siblings faced increased risk.
Folate-Rich Foods Spinach, Broccoli Cut Colorectal Cancer Risk
Colorectal cancer can be lowered by up to 7% by increasing dietary consumption of folate rich foods like spinach, broccoli or taking folate supplements.
New Therapy for Biliary Tract Cancer
The effects and mechanisms of microRNA-451a (miR-451a), which hinders the progression of gemcitabine-resistant biliary tract cancers, are under study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cancer Funding Becoming an Issue in the US Presidential Race Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests